Coalition for Epidemic Preparedness Innovations
GPTKB entity
Statements (117)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:organization
|
| gptkbp:advocates_for |
gptkb:legislation
global collaboration pandemic preparedness vaccine equity global health security vaccine innovation sustainable funding for vaccines |
| gptkbp:budget |
approximately $1 billion
|
| gptkbp:collaborations |
gptkb:governments
academic institutions international organizations pharmaceutical companies research institutions non-governmental organizations biopharmaceutical companies global health organizations vaccine development strengthen health systems multi-stakeholder |
| gptkbp:financial_performance |
published yearly
|
| gptkbp:focus |
vaccine development
epidemic preparedness |
| gptkbp:focus_area |
gptkb:Company
community engagement clinical trials data sharing vaccine efficacy vaccine distribution vaccine equity pandemic response emerging infectious diseases vaccine safety vaccine research vaccine research and development vaccine platforms vaccine manufacturing regulatory pathways |
| gptkbp:founded |
gptkb:2017
|
| gptkbp:founder |
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:World_Economic_Forum gptkb:Wellcome_Trust gptkb:Norwegian_Ministry_of_Foreign_Affairs |
| gptkbp:goal |
equitable access to vaccines
accelerate vaccine development reduce time to develop vaccines increase vaccine availability ensure equitable access to vaccines accelerate vaccine development for epidemics improve global health infrastructure |
| gptkbp:headquarters |
gptkb:Oslo,_Norway
|
| gptkbp:healthcare |
infectious disease outbreaks
|
| https://www.w3.org/2000/01/rdf-schema#label |
Coalition for Epidemic Preparedness Innovations
|
| gptkbp:impact |
gptkb:healthcare_organization
public health pandemic preparedness global health strengthening health systems global vaccination efforts preparedness for future pandemics response to emerging infectious diseases |
| gptkbp:is_engaged_in |
stakeholders
|
| gptkbp:leadership |
gptkb:CEO
CEO Richard Hatchett |
| gptkbp:membership |
over 30 countries
|
| gptkbp:mission |
prevent and respond to epidemics
|
| gptkbp:network |
global health network
|
| gptkbp:outcome |
improved vaccine access
|
| gptkbp:partnership |
gptkb:football_match
gptkb:GAVI_Alliance gptkb:World_Health_Organization gptkb:WHO gptkb:private_sector collaborative research |
| gptkbp:project |
vaccine development projects
Vaccine Development for COVID-19 Vaccine Development for Chikungunya Vaccine Development for Ebola Vaccine Development for Lassa Fever Vaccine Development for MERS Vaccine Development for Nipah Virus Vaccine Development for Rift Valley Fever Vaccine Development for Zika Virus |
| gptkbp:receives_funding_from |
gptkb:corporate_sponsorships
$1 billion public and private sources government grants philanthropic donations innovative financing vaccine candidates |
| gptkbp:related_model |
gptkb:collaboration
|
| gptkbp:reports_to |
gptkb:report
|
| gptkbp:research |
infectious diseases
vaccine technologies |
| gptkbp:research_areas |
vaccine technology
|
| gptkbp:research_focus |
vaccine platforms
|
| gptkbp:responds_to |
gptkb:Detective
gptkb:COVID-19_pandemic SARS outbreak MERS outbreak Nipah virus outbreak |
| gptkbp:strategic_importance |
2021-2025
vaccine research enhance global preparedness |
| gptkbp:supports |
research institutions
|
| gptkbp:sustainability_initiatives |
gptkb:COVAX
gptkb:Vaccine_Alliance partnerships with biotech companies CEPI's Blueprint for Action Vaccine Development Fund |
| gptkbp:tactics |
equitable access to vaccines
funding vaccine research |
| gptkbp:training |
gptkb:rapid_response
|
| gptkbp:website |
cepi.net
|
| gptkbp:bfsParent |
gptkb:initiative
gptkb:WHO |
| gptkbp:bfsLayer |
3
|